The Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of Onureg (azacitidine tablets; CC-486) as a maintenance therapy in adult patients with acute myeloid leukemia.
Selumetinib was recommended for conditional marketing authorisation in the European Union for the treatment of symptomatic, inoperable plexiform neurofibromas in pediatric patients with neurofibromatosis type 1 aged three years and above.
The European Commission has granted conditional marketing authorisation for Jemperli (dostarlimab), a programmed death receptor-1 (PD-1)-blocking antibody, for use in women with mismatch repair-deficient (dMMR)/microsatellite instability-high (MSI-H) recurrent or advanced endometrial cancer who have progressed on or following prior treatment with a platinum containing regimen.
Inivata and Agendia Inc. have entered a commercialization agreement for the RaDaR MRD liquid biopsy assay in breast cancer.
In surveys, as many as 15% of Americans say that they will not get a COVID-19 vaccine under any circumstances, and another 17% are in the “wait-and-see” category, holding out to observe how others fare.If these numbers are correct, the U.S. has almost no wiggle room as it strives to reach herd immunity to COVID-19.
Taofeek K. Owonikoko was named chief of the Division of Hematology/Oncology at UPMC Hillman Cancer Center and the Department of Medicine at the University of Pittsburgh.
Suresh S. Ramalingam was named editor-in-chief of the journal Cancer, with a five-year editorship beginning July 1.
Douglas S. Tyler was elected the 2021-2022 president of the Society of Surgical Oncology.
Stand Up To Cancer will receive a $4 million grant from Mirati Therapeutics Inc. to develop new approaches to treat patients with KRAS mutant cancers, as a part of the SU2C Catalyst program.
Two Little Rock Central High School students received the inaugural Winthrop P. Rockefeller Cancer Institute Special Award for Outstanding Cancer Research at the Arkansas State Science and Engineering Fair.
